RxDoctor Payments Data

Richard Zuckerman, MD

Infectious Disease · Lebanon, NHNPI 1891807541

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in NH, where the typical reported total is $97.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$409,888in research payments, 2019–2025

Across 11 payments — averaging $37,263 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$392K
  • Invivyd Inc$18K

How this compares

$0 in reported general payments places this provider in the 30th percentile of 33 infectious disease providers in New Hampshire.

See all infectious disease providers in New Hampshire

Medicare billing

Part B allowed, 2024
$33,857
Medicare patients
198
Services billed
261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala41$171,060
TivicayDolutegravir Sodium28$66,307
IsentressRaltegravir Potassium12$26,000
Cefazolin Sodium19$939
CeftriaxoneCeftriaxone Sodium19$483
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$329

Paid to pharmacies, not to this prescriber.

Other infectious disease in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →